Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
19.31
-0.23 (-1.18%)
At close: Feb 13, 2026

Sansure Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
11,08713,00111,18712,74723,60045,580
Market Cap Growth
-1.96%16.22%-12.24%-45.99%-48.22%-
Enterprise Value
8,2748,9826,4087,41718,71641,873
Last Close Price
19.3122.1018.5520.0534.8966.22
PE Ratio
47.9247.1730.766.5810.5217.42
Forward PE
35.768.198.198.1912.2013.61
PS Ratio
6.648.9211.111.985.239.57
PB Ratio
1.541.771.511.703.709.61
P/TBV Ratio
1.901.881.621.723.739.67
P/FCF Ratio
---6.3715.6917.99
P/OCF Ratio
55.4547.37256.934.9812.5717.25
EV/Sales Ratio
4.966.166.361.154.158.79
EV/EBITDA Ratio
28.0533.5380.303.277.2813.52
EV/EBIT Ratio
71.6270.58-3.387.4113.64
EV/FCF Ratio
-38.50--3.7112.4416.53
Debt / Equity Ratio
0.150.060.010.000.000.01
Debt / EBITDA Ratio
3.741.530.400.010.010.02
Debt / FCF Ratio
---0.010.010.02
Net Debt / Equity Ratio
-0.40-0.59-0.64-0.75-0.73-0.87
Net Debt / EBITDA Ratio
-10.15-16.08-59.44-2.48-1.81-1.34
Net Debt / FCF Ratio
13.5129.3713.64-2.82-3.10-1.63
Asset Turnover
0.190.170.110.790.721.56
Inventory Turnover
0.910.730.778.043.975.69
Quick Ratio
4.397.055.984.488.296.91
Current Ratio
4.887.676.474.798.997.38
Return on Equity (ROE)
3.09%3.06%4.66%27.88%40.31%98.69%
Return on Assets (ROA)
0.80%0.93%-0.15%16.86%25.17%62.94%
Return on Invested Capital (ROIC)
2.53%3.86%-0.78%102.20%186.47%495.78%
Return on Capital Employed (ROCE)
1.40%1.60%-0.30%28.90%39.30%64.40%
Earnings Yield
2.45%2.12%3.25%15.19%9.50%5.74%
FCF Yield
-1.94%-1.13%-3.11%15.69%6.37%5.56%
Dividend Yield
2.78%2.38%2.49%6.47%2.18%1.15%
Payout Ratio
122.80%97.39%110.10%33.92%19.61%11.51%
Buyback Yield / Dilution
-14.18%0.05%-0.26%0.59%-6.55%-3.97%
Total Shareholder Return
-11.43%2.42%2.23%7.07%-4.37%-2.82%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.